Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Ya-Huey Chen
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=5.947
------>paper_class3=2
------>paper_class2=1
------>vol=6
------>confirm_bywho=tzengcr
------>insert_bywho=mpwu
------>Jurnal_Rank=11.1
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=1961
------>medlineContent=
------>unit=E0111
------>insert_date=20081205
------>iam=4
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=
------>score=500
------>journal_name=J Thromb Haemost
------>paper_name=Angiostatin K1-3 induces E-selectin via AP1 and Ets1: a mediator for anti-angiogenic action of K1-3.
------>confirm_date=20081205
------>tch_id=093043
------>pmid=18761727
------>page1=1953
------>fullAbstract=BACKGROUND: Angiostatin, a circulating angiogenic inhibitor, is an internal fragment of plasminogen and consists of several isoforms, K1-3 included. We previously showed that K1-3 was the most potent angiostatin to induce E-selectin mRNA expression. The purpose of this study was to identify the mechanism responsible for K1-3-induced E-selectin expression and investigate the role of E-selectin in the anti-angiogenic action of K1-3. METHODS AND RESULTS: Quantitative real time RT-PCR and Western blotting analyses confirmed a time-dependent increase of E-selectin mRNA and protein induced by K1-3. Subcellular fractionation and immunofluorescence microscopy showed the co-localization of K1-3-induced E-selectin with caveolin 1 (Cav1) in lipid rafts in which E-selectin may behave as a signaling receptor. Promoter-driven reporter assays and site-directed mutagenesis showed that K1-3 induced E-selectin expression via promoter activation and AP1 and Ets-1 binding sites in the proximal E-selectin promoter were required for E-selectin induction. The in vivo binding of both protein complexes to the proximal promoter was confirmed by chromatin immunoprecipitation (ChIP). Although K1-3 induced the activation of ERK1/2 and JNK, only repression of JNK activation attenuated the induction of E-selectin by K1-3. A modulatory role of E-selectin in the anti-angiogenic action of K1-3 was manifested by both overexpression and knockdown of E-selectin followed by cell proliferation assay. CONCLUSIONS: We show that K1-3 induced E-selectin expression via AP1 and Ets-1 binding to the proximal E-selectin promoter (-356/+1), which was positively mediated by JNK activation. Our findings also demonstrate E-selectin as a novel target for the anti-angiogenic therapy.
------>tmu_sno=None
------>sno=20482
------>authors2=Yi-Hsien Huang
------>authors3=Hua-Lin Wu
------>authors4=Ming-Ping Wu
------>authors5=Yi-Zih Kuo
------>authors6=Wen-Tsan Chang, Kung-Chu Lu, Li-Wha Wu
------>authors6_c=
------>authors=Ya-Huey Chen
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=Angiostatin K1-3 induces E-selectin via AP1 and Ets1: a mediator for anti-angiogenic action of K1-3.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2008
------>submit_flag=None
------>publish_month=8
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z